TIDMAZN

RNS Number : 5589O

AstraZeneca PLC

01 June 2020

1 June 2020 15:00 BST

Block Listing Six Monthly Return

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 1 June 2020

 
 Name of applicant:                                  ASTRAZENECA PLC 
 Name of scheme:                                     ASTRAZENECA SHARE OPTION PLAN; ASTRAZENECA SAVINGS-RELATED SHARE 
                                                     OPTION PLAN; ASTRAZENECA 
                                                     ALL-EMPLOYEE SHARE PLAN; ASTRAZENECA PLC 2012 SAVINGS-RELATED 
                                                     SHARE OPTION SCHEME 
                                                    ------------------------------------------------------------------ 
 Period of return:          From:                    1 December 2019           To:            31 May 2020 
                           -----------------------  ------------------------  -------------  ------------------------- 
 Balance of unallotted securities under scheme(s) 
  from previous return:                              1,111,666 
                                                    ------------------------------------------------------------------ 
 Plus: The amount by which the block scheme(s) has 
  been increased since the date of the last 
  return (if any increase has been applied for):     0 
                                                    ------------------------------------------------------------------ 
 Less: Number of securities issued/allotted under 
  scheme(s) during period (see LR3.5.7G):            348,131 
                                                    ------------------------------------------------------------------ 
 Equals: Balance under scheme(s) not yet 
  issued/allotted at end of period:                  763,535 
                                                    ------------------------------------------------------------------ 
 
 
 
 Name of contact:                CAMILLA JOHNSTONE 
 Telephone number of contact:    020 3749 5000 
                                ------------------

AstraZeneca

AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @ AstraZeneca .

Contacts

For details on how to contact the Investor Relations Team, please click here . For Media contacts, click here .

Adrian Kemp

Company Secretary

AstraZeneca PLC

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BLRSSAFFFESSEFM

(END) Dow Jones Newswires

June 01, 2020 10:00 ET (14:00 GMT)

Astrazeneca (LSE:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Astrazeneca Charts.
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Astrazeneca Charts.